S12 Ep1: Magic Mushrooms Treating Depression

In this episode we will discuss "Magic Mushrooms" with our guest, Del Jolly. ​Del Jolly, Co-Founder of Umbo, Unlimited Sciences and expert in functional mushrooms, states the research at Unlimited Sciences collects real-world data on psychedelic use so that we can more quickly understand how to use these drugs safely and effectively for our health and overall wellbeing. Advocate & Educator. Focused on shifting the cultural narrative, Del worked as part of Decriminalize Denver and Charlotte’s Web CBD before co-founding Unlimited Sciences, a psychedelic research nonprofit partnered with the likes of Johns Hopkins University. He believes functional mushrooms have just as much, if not more, potential than psychedelics and is committed to exploring and unearthing everything we can. “With a focus on mental health becoming an important topic, the ways in which we address these issues are changing. Decriminalizing psychedelics, before legalization, is the most equitable solution we currently have under our system. And allowing humans to take their health and well-being into their own hands, without the fear of criminal repercussions isn't only the right thing to do, but the moral thing. Decriminalization and then the legalization of psychedelics is long overdue,” says Jolly. ​Magic mushrooms are wild or cultivated mushrooms that contain psilocybin, a naturally-occurring psychoactive and hallucinogenic compound. Psilocybin is considered one of the most well-known psychedelics, according to the Substance Abuse and Mental Health Services Administrations (SAMHSA).1 Psilocybin is classified as a Schedule I drug, meaning that it has a high potential for misuse and has no currently accepted medical use in treatment in the United States. (Credits: Verywell Health)